We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.18B
AUM Growth
-$419M
Cap. Flow
-$653M
Cap. Flow %
-12.61%
Top 10 Hldgs %
12.12%
Holding
1,157
New
156
Increased
241
Reduced
474
Closed
210

Sector Composition

Rank Sector Weight
1 Technology 18.78%
2 Financials 17.57%
3 Healthcare 14.1%
4 Industrials 10.7%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
1076
DELISTED
Immunogen Inc
IMGN
-209,500
Closed -$561K
ONCT
1077
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-45
Closed -$49K
FRTX
1078
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-151
Closed -$144K
CTG
1079
DELISTED
Computer Task Group, Inc.
CTG
-26,900
Closed -$126K
KDNY
1080
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-3,142
Closed -$195K
ALR
1081
DELISTED
AlerisLife Inc
ALR
-12,651
Closed -$242K
HZN
1082
DELISTED
Horizon Global Corporation
HZN
-31,740
Closed -$633K
LCI
1083
DELISTED
Lannett Company, Inc.
LCI
-14,798
Closed -$1.57M
STOR
1084
DELISTED
STORE Capital Corporation
STOR
-22,380
Closed -$660K
SJI
1085
DELISTED
South Jersey Industries, Inc.
SJI
-97,475
Closed -$2.88M
EXTN
1086
DELISTED
Exterran Corporation
EXTN
-68,058
Closed -$1.07M
MANT
1087
DELISTED
Mantech International Corp
MANT
-65,273
Closed -$2.46M
EPZM
1088
DELISTED
Epizyme, Inc
EPZM
-22,400
Closed -$220K
COHR
1089
DELISTED
Coherent Inc
COHR
-7,400
Closed -$818K
FLOW
1090
DELISTED
SPX FLOW, Inc.
FLOW
-13,650
Closed -$422K
GTS
1091
DELISTED
Triple-S Management Corporation
GTS
-13,921
Closed -$290K
SC
1092
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-255,640
Closed -$3.11M
FLXN
1093
DELISTED
Flexion Therapeutics, Inc.
FLXN
-18,400
Closed -$360K
RNET
1094
DELISTED
RigNet, Inc.
RNET
-15,399
Closed -$233K
MNTA
1095
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-30,500
Closed -$357K
DZSI
1096
DELISTED
DZS Inc. Common Stock
DZSI
-4,250
Closed -$24K
BGG
1097
DELISTED
Briggs & Stratton Corp.
BGG
-31,600
Closed -$589K
PTLA
1098
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-14,200
Closed -$322K
SDRL
1099
DELISTED
Seadrill Limited Common Stock
SDRL
-2,598
Closed -$1.65M
TIVO
1100
DELISTED
Tivo Inc
TIVO
-174,672
Closed -$3.4M

Similar funds

Jacobs Levy Equity Management's Q4 2016 Portfolio in Review

As of Q4 2016, Jacobs Levy Equity Management held 1,157 positions worth $5.18B, down 7.5% from $5.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $653M in Q4 2016, closing 210 positions and reducing 474 holdings. Its most notable exit was Nike, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Express Scripts Holding Company worth $34.6M.

  • Jacobs Levy Equity Management's largest Q4 2016 buy was Express Scripts Holding Company: 502,999 shares worth $34.6M.
  • Jacobs Levy Equity Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2016, an estimated $34.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $34.2M.
  • Jacobs Levy Equity Management fully exited Nike in Q4 2016, selling an estimated $39.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.18B portfolio in Q4 2016.
  • Jacobs Levy Equity Management opened 156 new positions and closed 210 in Q4 2016.
  • Jacobs Levy Equity Management's portfolio value fell 7.5% quarter-over-quarter to $5.18B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2016, filed 14 Feb 2017.